Ashton Tweed Connection Vol. 4 No. 2

Share

Featuring CEO Interview with Cynthia Schwalm, EVP, North America Commercial Operations, Ipsen

 

Your Issue of Ashton Tweed Connection Vol. 4 No. 2 is Here!

Ashton Tweed Homepage

Our Site

View Ashton Tweed Connection in Browser

Vol. 4
No. 2

Ashton Tweed can meet your specialized retained search & interim talent needs in the life sciences industry.

CEO Leadership Series: Cynthia Schwalm, EVP, North America Commercial Operations, Ipsen

CEO Leadership Series: Cynthia Schwalm, EVP, North America Commercial Operations, Ipsen
In the three years since Cynthia Schwalm joined Ipsen’s North America operations, she’s handled the enviable challenge of managing aggressive growth and acquiring new assets for the pharmaceutical company…
Read More

5 Ways to Navigate Ethics in the Life Sciences
5 Ways to Navigate Ethics in the Life Sciences
With gene editing clinical trials starting in humans and drug pricing taking center stage in our industry, it’s important to remember our ethics. For most companies, an ethical business means playing by the rules, working honestly…
Read More 5 Ways to Navigate Ethics in the Life Sciences

7 Tips of Crafting the Perfect Cover Letter
7 Tips of Crafting the Perfect Cover Letter
While finding and applying for jobs has become easier with the internet, the fundamentals of the process are the same. Writing skills, especially in the age of emails, are still extremely important. Whether your cover letter is being…
Read More 7 Tips of Crafting the Perfect Cover Letter

Subscribe Now!

Don’t miss out
on top hiring news!
Ashton Tweed’s Weekly Digest email covers hiring, firing, & retiring news in the life sciences. Also, check out our:
Featured Candidates Featured Candidates
Upcoming Events Upcoming Events
Recent Editions Recent Editions
point

Patent Office Hands Win in CRISPR Battle to Broad Institute
Patent Office Hands Win in CRISPR Battle to Broad Institute
The patent fight over the gene-editing technique CRISPR has a winner – the Broad Institute of Cambridge, MA. The battle began when the University of California, Berkeley challenged a dozen patents held by the Broad Institute…
Read More Patent Office Hands Win in CRISPR Battle to Broad Institute

Chan-Zuckerberg health project injects $50M into new Biohub Scientists
Chan-Zuckerberg health project injects $50M into new Biohub Scientists
Husband-and-wife team Mark Zuckerberg and Priscilla Chan have given around $50M to fund 47 “CZ Biohub” investigators across U.S. academia. The couple pledged to invest around $3B over the next 10 years…
Read More Chan-Zuckerberg health project injects $50M into new Biohub Scientists

The top 10 drug launches of 2017
The top 10 drug launches of 2017
After a slow year for new drug approvals with the FDA only approving 22 meds in 2016, we are looking forward to how drugmakers do in 2017. No matter how many new drugs are approved this year, there are sure to…
Read More The top 10 drug launches of 2017

5 Highest Paid Biopharma CEOs of 2016
5 Highest Paid Biopharma CEOs of 2016
The New York Times recently published a list of the 200 highest paid chief executive officers in the United States as researched and reported by Equilar. Check out where the top five biopharma CEOs ranked on that list…
Read More 5 Highest Paid Biopharma CEOs of 2016

Life Sciences Collaborative’s 4th Annual Conference
When: March 7, 2017
Where: Philadelphia, PA
Life Sciences Collaborative presents “Why Invest in Philadelphia Now? – Converting Risk Capital to Success Stories”…
Read More
Life Sciences Collaborative's 4th Annual Conference

FierceMedicalDevices’ 2016 Fierce 15
2016’s Fierce 15 are redefining what it means to be a medical device. If they’re not making big bets on new technologies, they’re reimagining existing ones. From video-game based therapies and liquid…
Read More FierceMedicalDevices' 2016 Fierce 15

HHS Exempts positions from FDA Hiring Freeze
FDA medical officers – including those involved with product review and post-market safety monitoring across CDER, CBER and CDRH – will be exempt from the federal hiring freeze, according to an HHS memo. The full list of exempt…
Read More HHS Exempts positions from FDA Hiring Freeze

About Ashton Tweed, Ltd.
At the very core of Ashton Tweed’s talent-acquisition and talent-placement business is a robust professional force of highly experienced life sciences industry experts. These uniquely talented professionals are deployed throughout Ashton Tweed’s diverse range of service offerings to solve our clients’ human capital and management needs.
Ashton Tweed on Twitter Ashton Tweed on Facebook Ashton Tweed on Google+ Ashton Tweed on LinkedIn

Contact Ashton Tweed

©2017 Ashton Tweed. All rights reserved.

Share

Leave a Reply

Your email address will not be published. Required fields are marked *